Home » Stocks » Tricida

Tricida, Inc. (TCDA)

Stock Price: $9.01 USD -0.18 (-1.96%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 450.94M
Revenue (ttm) n/a
Net Income (ttm) -234.57M
Shares Out 50.05M
EPS (ttm) -4.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $9.01
Previous Close $9.19
Change ($) -0.18
Change (%) -1.96%
Day's Open 9.17
Day's Range 8.97 - 9.29
Day's Volume 277,864
52-Week Range 8.50 - 44.30

More Stats

Market Cap 450.94M
Enterprise Value 262.39M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 50.05M
Float 38.98M
EPS (basic) -4.73
EPS (diluted) -4.72
FCF / Share -4.05
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.39M
Short Ratio 5.44
Short % of Float 8.69%
Beta 1.06
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.99
Revenue n/a
Operating Income -233.29M
Net Income -234.57M
Free Cash Flow -202.30M
Net Cash 188.55M
Net Cash / Share 3.77
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -33.50%
ROE -81.19%
ROIC -54.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 2
Overweight 0
Hold 1
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

(116.43% upside)
Current: $9.01
Target: 19.50
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-179-104-47.12-27.18
Net Income-177-103-41.29-28.65
Shares Outstanding47.5222.152.141.83
Earnings Per Share-3.72-4.64-19.32-15.69
Operating Cash Flow-130-94.86-40.40-23.12
Capital Expenditures-1.42-0.86-1.00-0.25
Free Cash Flow-131-95.71-41.41-23.36
Cash & Equivalents30824167.5126.45
Total Debt68.2338.07--
Net Cash / Debt24020367.5126.45
Book Value264195-88.04-47.63
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Tricida, Inc.
Country United States
Employees 195
CEO Gerrit Klaerner

Stock Information

Ticker Symbol TCDA
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: TCDA
IPO Date June 28, 2018


Tricida, a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (CKD). The company has completed a Phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California.